Literature DB >> 30694020

Hypospadias risk is increased with maternal residential exposure to hormonally active hazardous air pollutants.

Kunj R Sheth1,2,3, Erin Kovar4, Jeffrey T White1,2,3, Tiffany M Chambers4, Erin C Peckham-Gregory4,5, Marisol O'Neill3,6, Peter H Langlois7, Abhishek Seth1,2,3, Michael E Scheurer4,5, Philip J Lupo4,5, Carolina J Jorgez1,2,3.   

Abstract

BACKGROUND: With the increasing birth prevalence of hypospadias, there is growing concern for pollutant exposure interfering with normal penile development. We assess the association between hypospadias and hormonally active hazardous air pollutants (HAHAPs) through a nationwide database of hazardous air pollutants and the Texas Birth Defects Registry (TBDR).
METHODS: Using the TBDR, we identified 8,981 nonsyndromic isolated hypospadias cases from 1999 to 2008. Birth certificate controls were matched for birth year at a 10:1 ratio to cases. Estimated HAHAP concentrations from the 2005 U.S. EPA National-Scale Air Toxics Assessment were used to assign exposure based on maternal residence at birth. Exposure levels were categorized as quintiles based on the distribution in controls. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (CI) for each increasing exposure category of selected HAHAPs.
RESULTS: Of the 10 HAHAPs studied, seven were significantly associated with hypospadias risk. The HAHAP that was most strongly associated with hypospadias was phenol, which was associated with risk in all groups except the high exposure group. Cumulative HAHAP exposure demonstrated a modest increase in hypospadias risk (OR 1.15, 95% CI: 1.07-1.24, p < 0.001) in the medium and medium-high quintiles.
CONCLUSIONS: While maternal exposure to some HAHAPs was significantly associated with the risk of hypospadias in male offspring, the effects were modest, and no dose-response effects were observed. Future work should employ biomarkers of exposure to better delineate the relationship.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital malformation; genitalia; penis development; pollutant

Mesh:

Substances:

Year:  2019        PMID: 30694020      PMCID: PMC6868530          DOI: 10.1002/bdr2.1461

Source DB:  PubMed          Journal:  Birth Defects Res            Impact factor:   2.344


  44 in total

1.  Differences in exposure assignment between conception and delivery: the impact of maternal mobility.

Authors:  Philip J Lupo; Elaine Symanski; Wenyaw Chan; Laura E Mitchell; D Kim Waller; Mark A Canfield; Peter H Langlois
Journal:  Paediatr Perinat Epidemiol       Date:  2010-03       Impact factor: 3.980

2.  Is Hypospadias Associated with Prenatal Exposure to Endocrine Disruptors? A French Collaborative Controlled Study of a Cohort of 300 Consecutive Children Without Genetic Defect.

Authors:  Nicolas Kalfa; Françoise Paris; Pascal Philibert; Mattea Orsini; Sylvie Broussous; Nadège Fauconnet-Servant; Françoise Audran; Laura Gaspari; Hélène Lehors; Myriam Haddad; Jean-Michel Guys; Rachel Reynaud; Pierre Alessandrini; Thierry Merrot; Kathy Wagner; Jean-Yves Kurzenne; Florence Bastiani; Jean Bréaud; Jean-Stéphane Valla; Gérard Morisson Lacombe; Eric Dobremez; Amel Zahhaf; Jean-Pierre Daures; Charles Sultan
Journal:  Eur Urol       Date:  2015-05-23       Impact factor: 20.096

Review 3.  Hypospadias and urethral development.

Authors:  L S Baskin
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Traffic-related air pollution and the incidence of childhood central nervous system tumors: Texas, 2001-2009.

Authors:  Heather E Danysh; Laura E Mitchell; Kai Zhang; Michael E Scheurer; Philip J Lupo
Journal:  Pediatr Blood Cancer       Date:  2015-05-11       Impact factor: 3.167

Review 5.  Systematic Review to Compare Urothelium Differentiation with Urethral Epithelium Differentiation in Fetal Development, as a Basis for Tissue Engineering of the Male Urethra.

Authors:  Petra de Graaf; E Martine van der Linde; Peter F W M Rosier; Ander Izeta; Karl-Dietrich Sievert; J L H Ruud Bosch; Laetitia M O de Kort
Journal:  Tissue Eng Part B Rev       Date:  2016-12-02       Impact factor: 6.389

6.  Case-control study of maternal residential atrazine exposure and male genital malformations.

Authors:  A J Agopian; Philip J Lupo; Mark A Canfield; Peter H Langlois
Journal:  Am J Med Genet A       Date:  2013-03-13       Impact factor: 2.802

Review 7.  The Genetic and Environmental Factors Underlying Hypospadias.

Authors:  Aurore Bouty; Katie L Ayers; Andrew Pask; Yves Heloury; Andrew H Sinclair
Journal:  Sex Dev       Date:  2015-11-28       Impact factor: 1.824

8.  Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys.

Authors:  Frank H Pierik; Alex Burdorf; James A Deddens; Rikard E Juttmann; Rob F A Weber
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

9.  Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients.

Authors:  Xian-Yang Qin; Yoshiyuki Kojima; Kentaro Mizuno; Katsuhiko Ueoka; Koji Muroya; Mami Miyado; Hiroko Zaha; Hiromi Akanuma; Qin Zeng; Tomokazu Fukuda; Jun Yoshinaga; Junzo Yonemoto; Kenjiro Kohri; Yutaro Hayashi; Maki Fukami; Tsutomu Ogata; Hideko Sone
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of hypospadias: case-control study.

Authors:  Gillian Ormond; Mark J Nieuwenhuijsen; Paul Nelson; Mireille B Toledano; Nina Iszatt; Sara Geneletti; Paul Elliott
Journal:  Environ Health Perspect       Date:  2008-11-20       Impact factor: 9.031

View more
  1 in total

1.  Hypospadias Risk from Maternal Residential Exposure to Heavy Metal Hazardous Air Pollutants.

Authors:  Jeffrey T White; Erin Kovar; Tiffany M Chambers; Kunj R Sheth; Erin C Peckham-Gregory; Marisol O'Neill; Peter H Langlois; Carolina J Jorgez; Philip J Lupo; Abhishek Seth
Journal:  Int J Environ Res Public Health       Date:  2019-03-15       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.